Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.

× No keyword cloud information.

31 in total

1. Optimizing radionuclide imaging in the assessment of cardiac sarcoidosis.

Authors: John P Bois; Panithaya Chareonthaitawee
Journal: J Nucl Cardiol Date: 2015-08-13 Impact factor: 5.952

2. Expanding the Horizons of Nuclear Cardiology: Disease Management.

Authors: David Wolinsky
Journal: J Nucl Cardiol Date: 2015-10 Impact factor: 5.952

3. Diagnosis, therapeutic response assessment, and detection of disease recurrence in cardiac sarcoidosis: Integral role of cardiac PET.

Authors: Rafael Cabrera; Karthik Ananthasubramaniam
Journal: J Nucl Cardiol Date: 2016-01-25 Impact factor: 5.952

Review 4. Recommendations for ¹⁸F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations.

Authors: Shinichiro Kumita; Keiichiro Yoshinaga; Masao Miyagawa; Mitsuru Momose; Keisuke Kiso; Tokuo Kasai; Masanao Naya
Journal: J Nucl Cardiol Date: 2019-08 Impact factor: 5.952

Review 5. Emerging Tracers for Nuclear Cardiac PET Imaging.

Authors: Dong-Yeon Kim; Sang-Geon Cho; Hee-Seung Bom
Journal: Nucl Med Mol Imaging Date: 2018-05-08

6. 18F-fluorodeoxyglucose use after cardiac transplant: A comparative study of suppression of physiological myocardial uptake.

Authors: Renata Christian Martins Felix; Clécio Maria Gouvea; Christiane Cigagna Wiefels Reis; Jacqueline Sampaio Dos Santos Miranda; Ligia Beatriz Chaves Espinoso Schtruk; Alexandre Siciliano Colafranceschi; Cláudio Tinoco Mesquita
Journal: J Nucl Cardiol Date: 2018-06-14 Impact factor: 5.952

7. Continuing evolution in preparation protocols for ¹⁸FDG PET assessment of inflammatory or malignant myocardial disease.

Authors: John P Bois; Panithaya Chareonthaitawee
Journal: J Nucl Cardiol Date: 2016-03-25 Impact factor: 5.952

Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.

1. Optimizing radionuclide imaging in the assessment of cardiac sarcoidosis.

2. Expanding the Horizons of Nuclear Cardiology: Disease Management.

3. Diagnosis, therapeutic response assessment, and detection of disease recurrence in cardiac sarcoidosis: Integral role of cardiac PET.

Review 4. Recommendations for ¹⁸F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations.

Review 5. Emerging Tracers for Nuclear Cardiac PET Imaging.

6. 18F-fluorodeoxyglucose use after cardiac transplant: A comparative study of suppression of physiological myocardial uptake.

7. Continuing evolution in preparation protocols for ¹⁸FDG PET assessment of inflammatory or malignant myocardial disease.

8. Evaluation of a low-carbohydrate diet-based preparation protocol without fasting for cardiac PET/MR imaging.

9. Challenges of cardiac inflammation imaging with F-18 FDG positron emission tomography.

10. Improving the worldwide quality of nuclear cardiology practice and research: The role of the official journal.

Review 4. Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations.

Review 5. Emerging Tracers for Nuclear Cardiac PET Imaging.

Review 4. Recommendations for ¹⁸F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations.